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ABSTRACT
Objectives The aim of this study was to explore the 
extent of implementation of the General Medical Services 
2018/2019 ‘frailty identification and management’ contract 
in general practitioner (GP) practices in England, and 
link implementation outcomes to a range of practice and 
Clinical Commissioning Group (CCG) factors.
Design A cross- sectional study design using publicly 
available datasets relating to the year 2018 for all GP 
practices in England.
Settings English general practices.
Data The analysis was conducted across 6632 practices 
in 193 CCGs with 9 995 558 patients aged 65 years or 
older.
Outcomes Frailty assessment rates, frailty coding rates 
and frailty prevalence rates, plus rates of medication 
reviews, falls assessments and enriched Summary Care 
Records (SCRs).
Analysis Summary statistics were calculated and 
multilevel negative binomial regression analysis was 
used to investigate relationships of the six outcomes with 
explanatory factors.
Results 14.3% of people aged 65 years or older were 
assessed for frailty, with 35.4% of these—totalling 5% 
of the eligible population—coded moderately or severely 
frail. 59.2% received a medications review, but rates of 
falls assessments (3.7%) and enriched SCRs (21%) were 
low. However, percentages varied widely across practices 
and CCGs. Practice differences in contract implementation 
were most strongly accounted for by their grouping within 
CCGs, with weaker but still important associations with 
some practice and CCG factors, particularly healthcare 
demand- related factors of chronic caseload and 
(negatively) % of patients aged 65 years or older.
Conclusion CCG appears the strongest determinant of 
practice engagement with the frailty contract, and fuller 
implementation may depend on greater engagement 
of CCGs themselves, particularly in commissioning 
suitable interventions. Practices understandably targeted 
frailty assessments at patients more likely to be found 
severely frail, resulting in probable underidentification of 
moderately frail individuals who might benefit most from 
early interventions. Frailty prevalence estimates based on 
the contract data may not reflect actual rates.
INTRODUCTION
Frailty is a dynamic and multidimensional 
state of increased vulnerability that often 
remains unspecified in primary care until a 
relatively minor event causes a significant 
health crisis1 resulting in loss of indepen-
dence.2 Frailty in the English population 
aged over 60 years was recently estimated at 
14%, rising to 65% of those aged 90 years and 
over.3 Frail elderly individuals are at higher 
risk of adverse health outcomes such as falls, 
disability, hospitalisation and mortality.4 
Emergent evidence suggests that appropriate 
interventions can potentially reverse frailty 
and its consequences, allowing people to stay 
at home for longer.5 6 This motivated changes 
to the 2017/2018 General Medical Services 
(GMS) contract for general practitioners 
(GPs) in England.7
The GMS contractual changes require GPs 
to identify frail patients and code them using 
‘an appropriate tool’7 coupled with a direct 
clinical validation of the level of frailty. For 
Strengths and limitations of this study
 ► To our knowledge, this is the first peer- reviewed 
study to evaluate the implementation of the General 
Medical Services (GMS) contractual requirements 
around patient frailty.
 ► The analysis was based on 2018 data for almost 
10 million patients at more than 6000 gener-
al practitioner practices across all 193 Clinical 
Commissioning Groups (CCGs).
 ► Advanced methods of analysis and a broad range of 
potentially explanatory practice- level and CCG- level 
factors were investigated.
 ► It is possible that we lacked some key explanatory 
variables, though we analysed commonly used indi-
cators of primary care demand and supply.
 ► The GMS contract data relating to practice ac-
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patients with moderate or severe frailty, general practices 
are then required to conduct a medication review, carry 
out a falls assessment if clinically indicated (introduced 
in 2018/2019), and where possible obtain consent to 
activate an enriched electronic Summary Care Record 
(SCR), which is automatically updated from the clinical 
record. Clinicians in other areas of the health and care 
system involved in the patient’s direct care can see and 
use the SCR.8 Collecting and analysing data on frailty 
prevalence and management could help policymakers to 
better plan care.8
GP practices are grouped into local Clinical Commis-
sioning Groups (CCGs). CCGs were established under the 
Health and Social Care Act 2013 and replaced primary 
care trusts. The aim was to shift commissioning respon-
sibilities from central National Health Service (NHS) 
England to the local CCGs9 10 so as to shape services to 
meet local needs. CCGs now control around two- thirds of 
the NHS budget and influence the activities of the prac-
tices of which they are composed, potentially including 
how they respond to implementing contractual require-
ments.9 10
The identification and management of frailty within 
the GMS contract replaced the ‘avoiding unplanned 
admissions’ enhanced service specification.11 However, 
GPs have historically not coded ‘frailty’; and may do so 
inconsistently.12 As such, implementing these changes 
may also be a challenge for primary care.13 The current 
study aimed to explore the extent of implementation of 
the frailty elements of the GMS contract in England and 
the variation in relation to a range of practice and CCG 
factors.
METHODS
Study design and sample
We used a cross- sectional study design that sourced 
multiple publicly available datasets relating to the finan-
cial year starting on 1 April 2018 for all GP practices in 
England.
Patients and public involvement
No patients or public were involved in this study.
The GMS contract dataset
Under the revised GMS contract, GP practice- based 
frailty assessments are an annual requirement, with data 
reported back to the NHS on an accumulative quarterly 
basis. Practices are expected to re- evaluate all patients 65 
years and over for frailty annually and reclassify where 
appropriate. Our analysis focused on the full data for 
financial year 2018–2019.14 The list of relevant frailty- 
related measures is summarised in online supplemental 
table S1. All measures are simple patient counts for each 
individual practice, such as the number of patients aged 
65 years or over assessed for frailty ‘using the appropriate 
tool’. No individual patient data are captured.
Outcome measures of identification and management of 
frailty
Using the raw contract data, we constructed six outcomes 
assessing different aspects of the frailty- related activity at 
each GP practice (online supplemental table S2). These 
outcomes addressed two key aspects of frailty activity: 
frailty identification and frailty management. Three 
outcomes concerned frailty identification: first, the frailty 
assessment rate represents the percentage of patients 
assessed for frailty out of the eligible practice population 
(ie, those aged 65 years or over). Second, the frailty coding 
rate is the percentage coded as moderately or severely frail 
out of those assessed. Finally, the frailty prevalence rate is 
the percentage coded moderately or severely frail out of 
the eligible population. We also report separate rates for 
the moderately frail and severely frail subgroups.
The remaining outcomes evaluated frailty manage-
ment against three key interventions specified in the 
contractual requirements for GPs: first, the percentage 
of severely frail patients who received a medication review. 
Second, the percentage of moderately or severely frail 
who received a falls assessment. Finally, the percentage of 
moderately or severely frail consenting to the activation 
of an enriched SCR. Falls assessment data are collected as 
two counts: the number referred to a ‘falls clinic’ and the 
number having a ‘falls discussion’. Only 5% of practices 
reported any falls discussions, but occasionally the sum 
across both exceeded the total number of frail patients, 
implying inclusion in both counts: therefore for an 
overall measure, we took the highest of the two counts at 
each practice.
Practice and CCG characteristics
Information on the characteristics of each individual GP 
practice and CCG was collected from a variety of publicly 
available online sources. We grouped these potential 
explanatory factors into three types: descriptive factors; 
healthcare capacity factors and healthcare demand factors. Brief 
descriptions follow; full details of each explanatory factor 
and the relevant source appear in online supplemental 
table S3.
Descriptive factors of practices were: list size; contract type 
(GMS, Personal Medical Services (PMS) or Alternative 
Provider Medical Services (APMS)); overall Quality and 
Outcomes Framework (QOF) score for 2018–201915; % 
of GPs who qualified in the UK; % of GPs under 35 years; 
% of GPs over 50 years and % of GPs who were female. 
Descriptive CCG factors were: total population size.
Healthcare capacity factors of practices were: number of full- 
time equivalent (FTE) GPs; number of FTE nurses (each 
expressed as a rate per 10 000 patients); the availability 
of a pharmacist in the practice. CCG capacity factors were: 
CCG total nurses per 10 000 registered patients and CCG 
total GPs per 10 000 registered patients.
Healthcare demand factors of practices were: local area 
rurality (urban major conurbation, urban city or town, 
rural town, rural village); Index of Multiple Depriva-
tion (IMD) 2015 (in national quintiles); % of registered 
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patients aged 65 years or over; % of patients from black 
and minority ethnic groups (BME); chronic caseload 
(mean number of QOF chronic conditions per registered 
patient). CCG demand factors were: population mean IMD 
quintile; rurality (predominantly rural, predominantly 
urban, urban with significant rural); chronic caseload; % 
population BME and % population aged 65 years or over. 
Healthcare region was an additional explanatory factor.
IMD is a UK government- generated measure of local 
area deprivation, constructed as a weighted mean of seven 
distinct domains of deprivation; income, employment, 
education, skills and training, health and disability, crime, 
barriers to housing and services and living environment.16
Factors measured on numerical or percentage scales 
were categorised into three, four or five reasonably sized 
groups, rather than treated as continuous measures, since 
the very large sample size allowed this. Examination of 
the data suggested that many relationships to outcomes 
were non- linear and categorised measures avoid assuming 
linearity; this also facilitated presentation of results as 
subgroup (‘marginal’) means for easier interpretation. 
Table 1 summarises the practice- level factors. The CCG- 
level factors are summarised in online supplemental table 
S4.
Statistical analysis
We conducted descriptive analysis for all six frailty 
outcomes at the practice, CCG and national (all- England) 
levels, using the full cohort of 6632 practices with patients 
aged 65 years or over in the contract dataset. The usable 
practice sample varied by outcome: practices that 
conducted no frailty assessments did not contribute to 
analyses of outcomes for patients assessed for frailty; and 
practices that coded no patients as frail did not contribute 
to analysis of outcomes for patients coded as frail.
Multilevel negative binomial regression (NBR) was 
used to investigate relationships between the six frailty 
outcomes and practice- level and CCG- level explanatory 
factors. The dependent variable was the raw numerator 
for the outcome (eg, number of patients assessed) and 
the exposure variable the raw denominator (eg, number 
eligible for assessment), at each practice. Dispersion was 
assumed proportional to each practice denominator and 
robust estimates of variance, making no distributional 
assumptions and allowing for correlations between prac-
tices within CCGs, used to account for any differences 
away from a true negative binomial distribution.17 Online 
supplemental figure S1 and S2 depict the distributions 
of the practice numerators for each outcome measure 
broken down by practice list size; all outcomes were 
highly right- skewed with a long tail, as is typical for a nega-
tive binomial distribution. NBR analysis was undertaken 
in a two- stage process. At stage 1, we performed univar-
iate regressions against each practice- level and CCG- level 
explanatory factor (plus healthcare region) separately 
and identified those with an association with the outcome 
at p≤0.1—a high p value was used to avoid prematurely 
rejecting potentially important relationships. At stage 2, 
all identified factors were used together in a multilevel 
multivariate backwards stepwise NBR removing variables 
not significant at p≤0.05.
To facilitate interpretation, results are reported in the 
form of marginal (subgroup) means adjusted for all other 
factors in each model. Each marginal mean represents 
the adjusted mean incidence rate across practices in the 
subgroup.
Missing or unreliable data resulted in a slightly reduced 
sample for NBR analyses. Ninety- eight (98) practices 
with a reported list size that differed by more than 20% 
between the contract dataset and the workforce dataset 
were excluded due to concerns that their workforce data 
may be out of date or unreliable for other reasons. These 
practices tended to be very small (mean patient list size 
2595). Some practices lacked information on certain 
explanatory variables: the largest number being 270 
(4.3%) missing data on GP place of qualification, age and 
gender (online supplemental table S3). The maximum 
NBR analysis sample was 6534 practices, though as with 
the descriptive analysis the usable sample varied by 
outcome. Some practices conducted no frailty assess-
ments and to assess robustness against this, we repeated 
the NBR excluding these from relevant analyses.
To assess the degree to which practice- level and 
CCG- level factors along with mean differences between 
CCGs explained the variation in the frailty outcomes, 
we used the method proposed by Zheng and Agresti,18 
of computing correlations between the observed and 
model- based predicted practice scores. We used the NBR 
models to obtain predicted outcome scores for each prac-
tice based on (1) the practice and CCG factors in the 
model, (2) the CCG ‘Empirical Bayes’ means, (3) factors 
plus CCG means. Empirical Bayes estimated the mean 
practice score in each CCG after removal of variation due 
to practice and CCG factors.
RESULTS
National (all-England) level
The 2018/2019 GMS contract dataset indicated a total 
population of patients eligible for frailty assessment across 
all 6632 GP practices in England, of 9 995 558 people aged 
65 years or older. Of these, 1 435 322 (14.3%) received an 
assessment for frailty, of which 326 037 (22.7% of those 
assessed) were subsequently coded as moderately frail and 
183 041 (12.7%) as severely frail. This yields a prevalence 
rate in all patients aged 65 years or over of 5% with 3.2% 
and 1.8% moderately and severely frail, respectively. The 
incidence of frailty management outcomes were: 59.2% 
of severely frail patients received a medication review; 
3.7% of moderately and severely frail patients received a 
falls assessment, and 21% gave consent to activate their 
enriched SCR (table 2).
Practice and CCG levels
Figure 1 and online supplemental figure S3 depict GP 
practice rates for each frailty outcome, with the % rate 
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Table 1 Summary of practice factors
Practice factor Number of practices % of practices
Descriptive factors
  Number of registered patients <4000 1121 17.2
4000 –<8000 2405 36.8
8000 <12 000 1700 26
12 000 and above 1308 20
  Contract type GMS 4571 70
PMS 1807 27.7
APMS 154 2.4
  Quality and Outcomes Framework overall score 1st quintile (<94.8) 1287 19.9
2nd quintile (94.8–<97.5) 1292 20
3rd quintile (97.5–<98.9) 1296 20
4th quintile (98.9–<99.8) 1290 19.9
5th quintile (99.8–100) 1302 20.1
  % of GPs UK qualified <33.3 1422 22.7
33.3–<66.7 1672 26.7
66.7 or more 3170 50.6
  % of GPs under 35 None 2965 47.3
<20 1146 18.3
20–<40 1520 24.1
40 or more 643 10.3




80 or more 912 14.6
  % of GPs female <25 1232 19.7
25–<45 1524 24.3
45–<65 2047 32.7
65 or more 1461 23.3
Healthcare capacity factors
  FTE GPs per 10 000 patients <2.5 468 7.4
2.5–<5.0 2423 38.3
5.0–<7.5 2319 36.7
7.5 or more 1112 17.6
  FTE nurses per 10 000 patients 1st quartile (<3.6) 1628 24
2nd quartile (3.6–<4.5) 1629 25
3rd quartile (4.5–<5.7) 1629 25
4th quartile (5.7 or more) 1628 24
  Pharmacist available in the practice No 5538 84.8
Yes (one or more) 996 15.2
Healthcare demand factors
  Rurality Urban major conurbation 3049 46.7
Urban city or town 2509 38.4
Rural town 705 10.8
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on the Y- axis and practices on the X- axis in rank order of 
descending rate size. The sample was smaller than 6632 
for some outcomes: the frailty coding rate only applied 
to practices that conducted frailty assessments (n=6293); 
medication and SCR rates to practices with a non- zero 
count of moderate or severe patients (n=5785); falls assess-
ment rates to those with severe patients (n=5264). For all 
outcomes, rates varied widely, from 0% up to—or close 
Practice factor Number of practices % of practices
  Index of Multiple Deprivation 1st national quintile (most 
deprived)
1858 28.4
2nd national quintile 1503 23
3rd national quintile 1230 18.8
4th national quintile 1071 16.4
5th national quintile (least 
deprived)
872 13.3




25 or more 902 13.8
  % of BME in practice LSOA <10 3718 56.9
10–<30 1363 20.9
30–<50 667 10.2
50 or more 786 12




0.75 or more 1179 18.2
APMS, Alternative Provider Medical Services; BME, black and minority ethnic; FTE, full- time equivalent; GMS, General Medical Services; GPs, general practitioners; 
LSOA, Lower Layer Super Output Area; PMS, Personal Medical Services.
Table 1 Continued
Table 2 English primary care frailty- related activity (N=9 995 558 eligible patients aged 65 years or over)
Number of practices 
contributing data*





Eligible patients assessed for frailty (assessment 
rate)
6632 1 435 322 14.3% 15.5%
Assessed patients coded as frail (coding rate) 6293 509 078 35.4% 49.5%
  Frailty coding rate: moderately frail subgroup 6293 326 037 22.7% 27.0%
  Frailty coding rate: severely frail subgroup 6293 183 041 12.7% 22.5%
Eligible patients coded as frail (prevalence rate) 6632 509 078 5.0% 5.6%
  Frailty prevalence rate: moderately frail 
subgroup
6632 326 037 3.2% 3.6%
  Frailty prevalence rate: severely frail subgroup 6632 183 041 1.8% 2.0%
Frailty management outcomes
Severely frail receiving a medications review 5264 108 507 59.2% 61.0%
Moderately or severely frail with a falls 
assessment‡
5785 19 069 3.7% 5.6%
Moderately or severely frail with an enriched SCR 5785 107 026 21% 23.8%
*Based on 6632 practices in the contract dataset. However, not all practices assessed patients for frailty, and some that did coded no patients as moderately/
severely frail, hence the practice sample was smaller for some outcomes.
†Rate in the combined population across all GP practices.
‡Was referred to a ‘falls clinic’ and/or had a falls discussion.
GP, general practitioner; SCR, Summary Care Record.
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to—100% and in most cases were highly skewed, with 
most practices scoring at the low end. Frailty assessment 
rates were below 5% for 50% of practices, but only 339 
(5.1%) reported zero assessments, indicating that 95% 
had engaged with the contract to at least some degree. 
Non- engaging practices were generally smaller (mean 
registered patients=5584 vs 8741; p<0.001), though the 
group also included some of the very largest practices.
For most outcomes, the mean practice rate was similar 
to the population rate (table 2). However, a notable excep-
tion was the mean practice frailty coding rate of 49.6%, 
compared with the population rate of 35.4%. Inspection 
of the data revealed this to be due to the population rate 
being dominated by larger practices. It should be noted 
that the NBR method estimates associations with practice- 
level rates and not with population rates.
CCG- level scores were derived by pooling the patients 
across all practices in each CCG. A large majority of 
practices in all CCGs engaged with the contract and 
all outcomes were derived for all CCGs (online supple-
mental figure S4). Variation between CCGs in contract- 
related activity was very wide, with percentages assessed 
for frailty ranging from 0.5% to 69.4%. Percentages 
coded moderately or severely frail ranged from 4.2% to 
100%, while prevalence rates ranged from 0.3% to 21.5%. 
CCG variation on the three frailty management outcomes 
was likewise very high.
Frailty identification outcomes and their associations with 
practice and CCG factors
Factors associated with frailty assessment rates
The number of people over 65 years of age assessed for 
frailty varied from 0% up to 100% by practice (figure 1). 
However, only 10% of practices had assessed more than 
50% of their eligible patients. After univariate and 
multivariate analyses, relationships were found (p<0.05) 
between frailty assessment and a number of practice and 
CCG factors (table 3 and figure 2).
Practice factors
Healthcare descriptive factors, higher assessment rates were 
associated with higher QOF scores (p=0.013). Practices in 
the lowest quintile of QOF scores had a mean assessment 
rate of 12.9%, rising to 15.8% at the fourth quintile and 
levelling off there, perhaps related to differences in QOF 
scores between the top two quintiles being very small. The 
relationship to % of UK- qualified GPs indicated a slightly 
raised rate at practices with 33.3% –<66.7% UK qualified 
(p=0.006) and assessment rates were also slightly higher 
at practices with 45% or more representation of female 
GPs (p=0.001).
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Healthcare capacity factors showed no significant relation-
ships to frailty assessment rates.
Healthcare demand factors, particularly notable was a 
negative curvilinear relationship between a larger older 
patient population and the percentage receiving a frailty 
assessment (p<0.001): practices with less than 10% of 
patients aged 65+ years had a mean assessment rate of 
23.4%, after which rates rapidly dropped until levelling 
off at 13% - 14% for practices with more than 15% aged 
65+ years. Conversely, frailty assessment rates rose as 
chronic caseload increased (p=0.008), slowly at first but 
more so with a chronic caseload greater than 0.65: prac-
tices with the highest caseloads had a mean assessment 
rate of 16.8% compared with 12% for practices with the 
lowest caseloads.
CCG factors
No CCG- level factors were significantly related to frailty 
assessment rates. However, rates differed by health region 
(p=0.012), with the mean rate being highest in the 
London region (20.3%), but almost half that level in the 
Midlands and East England (11.2%).
After exclusion of practices that made no assessments, 
all results stayed essentially the same.
Factors associated with frailty coding rates
Practice factors
Descriptive factors with statistically significant associations 
with rates of frailty coding in those assessed were prac-
tice size and % of UK- qualified GPs. Coding rates showed 
a curvilinear relationship to practice size (p<0.001), 
Table 3 Results from univariate and multivariate analyses of frailty assessment rates
Explanatory variable*
Univariate model Multivariate model
Marginal 
mean 95% CI P value†
Marginal 






1st quintile (<94.8) 13.40% 11.2% to 15.6% 0.008 12.90% 10.7% to 15.1% 0.013
2nd quintile (94.8–<97.5) 14.40% 12.2% to 16.6% 13.40% 11.3% to 15.4%
3rd quintile (97.5–<98.9) 15.20% 12.8% to 17.5% 14.20% 12.1% to 16.4%
4th quintile (98.9–<99.8) 17.20% 14.7% to 19.8% 15.80% 13.4% to 18.2%
5th quintile (99.8–100) 16.60% 14.2% to 19.1% 15.80% 13.5% to 18%
% of GPs UK 
qualified
<33.3 14.90% 12.7% to 17.2% 0.005 14.30% 12.2% to 16.5% 0.006
33.3–<66.7 17% 14.8% to 19.3% 16.20% 14% to 18.4%
66.7 or more 14.60% 12.7% to 16.6% 13.90% 12% to 15.9%
% of GPs 
female
<25 13.80% 11.7% to 15.9% 0.001 13.10% 11.1% to 15.2% 0.001
25–<45 14.10% 11.9% to 16.2% 13.40% 11.3% to 15.5%
45–<65 17.10% 15% to 19.3% 15.90% 13.9% to 18%
65 or more 15.50% 13.2% to 17.9% 14.50% 12.3% to 16.8%
Practice healthcare demand factors
% of patients 
65+
<10 20.10% 16.9% to 23.3% <0.001 23.40% 18.3% to 28.5% <0.001
10–<15 16.90% 14.5% to 19.4% 17.70% 14.8% to 20.5%
15–<20 14.30% 12.3% to 16.4% 14.40% 12.2% to 16.6%
20–<25 13.30% 11.3% to 15.3% 13% 10.9% to 15.1%
25 or more 13.50% 10.8% to 16.1% 12.80% 10.1% to 15.5%
Chronic 
caseload
< 0.45 16.30% 13.5% to 19.1% 0.077 12% 9.1% to 14.8% 0.008
0.45–<0.55 15.50% 13% to 18% 12.90% 10.7% to 15%
0.55–<0.65 13.70% 11.6% to 15.8% 13.30% 11.2% to 15.4%
0.65–<0.75 15.90% 13.6% to 18.2% 16.10% 13.7% to 18.5%
0.75 or more 15.90% 13.4% to 18.4% 16.80% 14% to 19.6%
Region
Region North of England 17% 13.4% to 20.6% 0.0007 16.30% 12.7% to 20% 0.012
Midlands and East 11% 8.6% to 13.4% 11.20% 8% to 13.7%
London 21.90% 16.5% to 27.4% 20.30% 15.1% to 25.5%
South West 13.70% 7.5% to 19.9% 14.50% 7.6% to 21.4%
South East 13.20% 10.2% to 16.2% 13.50% 10.1% to 17%
*Factors significantly associated with the outcome after multivariate backwards stepwise regression.
†P value for overall comparison of marginal means across all levels of the factor.
GPs, general practitioners.  on S
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increasing from a mean of 43.6% at the smallest prac-
tices (<4000 registered patients) then levelling off to 
52.8% and 52.5% at large (8000 –<12 000 patients) and 
very large (12 000 and above). Frailty coding rates also 
increased slightly with a higher % of UK- qualified GPs 
(p=0.002) (online supplemental table S5 and figure 2).
Healthcare demand factors, coding rates were highest 
in urban cities and towns (55.4%) and lowest in urban 
major conurbations (46.2%). Coding rates demonstrated 
a curvilinear increase with chronic caseload (p=0.011): 
from 44.8% in practices with the lowest levels of chronic 
caseload, then levelling off at 52%–53% beyond a case-
load score of 0.55 (online supplemental table S5 and 
figure 2).
CCG factors
Although significant, relationships to CCG GP staffing 
rates and IMD did not demonstrate a clear pattern 
(online supplemental table S5 and figure 2).
Factors associated with frailty prevalence rates
Practice factors
Descriptive factors, significant associations were found 
between frailty prevalence rates and contract type 
(p=0.02), QOF scores (p<0.001) and % of female GPs 
(<0.001). Prevalence rates were lower at practices with 
APMS contracts (3.6%) compared with a GMS (5.1%) 
or PMS contract (5.3%). Prevalence rates increased in 
linear fashion as QOF scores increased, though by only 
small degrees, and were also slightly higher at practices 
with beyond 45% representation of female GPs (online 
supplemental table S6 and figure 2).
Healthcare demand factors, a significant negative curvi-
linear relationship to numbers of older patients was 
apparent (p<0.001), with prevalence decreasing from 
7.4% at practices with <10% patients 65+ years, and level-
ling off at between 4% and 5% at practices with 20% 
or more 65+ years (online supplemental table S6 and 
figure 2).
CCG factors
Healthcare capacity factors, prevalence rates were associ-
ated with one healthcare capacity factor, nurse staffing 
levels, but with rates being counterintuitively lower as the 
CCG nurse- to- patients ratio increased (p<0.019) (online 
supplemental table S6 and figure 2).
Healthcare demand factors, there were observable relation-
ships with three CCG demand factors, IMD (p=0.042), % 
of BME (p=0.040) and chronic caseload (p<0.001). The 
relationship to IMD showed no clear pattern, and for % 
of BME was flat at 4%–5% except for CCGs in the upper 
Figure 2 Factors associated with frailty identification outcomes (p<0.05); marginal means from multivariate negative binomial 
analysis. APMS, Alternative Provider Medical Services; BME, black and minority ethnic; CCG, Clinical Commissioning Group; 
GMS, General Medical Services; GPs, general practitioners; IMD, Index of Multiple Deprivation; PMS, Personal Medical 
Services; QOF, Quality and Outcomes Framework.
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quartile of BME populations, at 7.7%. The relationship 
to chronic caseload started flat at 3%–4% for the first two 
quintiles, then rose gradually to reach 8.5% in the upper 
quintile of chronic caseload (online supplemental table 
S6 and figure 2).
When practices making no assessments were excluded 
from the analysis, the CCG demand factors of IMD 
(p=0.077) and % of BME (p=0.069) ceased to reach statis-
tical significance.
Frailty management outcomes and their associations with 
practice and CCG factors
Factors associated with medication review rates
Practice factors
Descriptive factors, rates of medication reviews in those 
coded as severely frail were associated with a larger 
percentage of UK- qualified GPs (p=0.038) but the effect 
was modest: the rate was quite flat at 59%–60% until the 
proportion of UK- qualified GPs reached two- thirds or 
more, when it rose to 62.5% (table 4 and online supple-
mental figure S5).
Healthcare capacity factors, rates of medication reviews 
showed a non- linear increase with practice ratio of 
FTE GPs to patients (p=0.030). The mean rate initially 
increased from 57.7% in practices with <2.5 FTE GPs per 
10 000 and then levelled off to around 61.5% at practices 
with a ratio of 5 or more (table 4 and online supplemental 
figure S5).
CCG factors
No significant relationships were detected to any CCG- 
level factors, or to health regions (table 4 and online 
supplemental figure S5).
Factors associated with falls assessment rates
Practice factors
Healthcare demand factors, rates of severely and moderately 
frail patients receiving a falls assessment were associated 
with rurality (p<0.010), with the rate slightly higher at 
practices located in urban cities and towns, 5.4%, and 
lowest at 3.6% for practices in rural villages (online 
supplemental figure S5 and online supplemental table 
S7).
CCG factors
Healthcare demand factors, fall assessment rates were highest 
at predominantly rural CCGs (6.3%) and lowest at CCGs 
with an urban–rural mix (3.9%) (online supplemental 
figure S5 and online supplemental table S7).
Factors associated with enriched SCR rates
Practice factors
Descriptive factors, enriched SCR rates demonstrated a 
relationship to number of registered patients (p=0.030) 
but with no clear pattern. A relationship to QOF scores 
was apparent (p<0.001), rising gradually from a mean of 
20.3% for practices in the lowest quintile of QOF scores to 
27.6% at those in the fourth quintile and then stabilising, 
though QOF scores differed only fractionally between 
the top two quintiles (online supplemental figure S5 and 
online supplemental table S8).
Healthcare capacity factors, rates of enriched SCRs also 
varied with practice GP staffing levels (p=0.039), but by 
only small degrees (online supplemental figure S5 and 
online supplemental table S8).
CCG factors
Healthcare capacity factors, in the form of overall GP 
(p=0.031) and nurse (p=0.006) staffing levels, were also 
associated with SCR consent rates, with a modest increases 
at higher staffing levels (third and fourth quintiles) in 
both cases (online supplemental figure S5 and online 
supplemental table S8).
Overall patterns of associations
The large majority of explanatory factors demonstrated 
statistically significant associations with at most one or 
two of the six frailty outcomes (online supplemental table 
S9). The only exceptions were higher QOF scores, associ-
ated with higher frailty assessment and prevalence rates, 
Table 4 Results from univariate and multivariate analyses of medication review rates
Explanatory variable*
Univariate model Multivariate model
Marginal mean 95% CI P value† Marginal mean 95% CI P value†
Practice descriptive factors
  % of GPs UK 
qualified
<33.3 58.5% 56.3% to 60.6% 0.008 59.0% 56.8% to 61.1% 0.038
33.3%–<66.7 59.6% 57.7% to 61.5% 59.6% 57.8% to 61.5%
66.7 or more 61.5% 60% to 63% 62.5% 60% to 62.9%
Practice healthcare capacity factors
  FTE GPs per 
10 000 patients
<2.5 57.9% 54.8% to 61% 0.010 57.7% 54.3% to 61% 0.030
2.5–<5.0 59.2% 57.6% to 60.8% 59.5% 57.9% to 61.1%
5.0–<7.5 61.4% 59.8% to 63% 61.4% 59.8% to 62.9%
7.5 or more 61.6% 59.4% to 63.9% 61.5% 59.2% to 63.8%
*Factors significantly associated with the outcome after multivariate backwards stepwise regression.
†P value for overall comparison of marginal means across all levels of the factor.
FTE, full- time equivalent; GPs, general practitioners.
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and increased use of enriched SCRs; and proportion of 
UK- qualified GPs, associated with assessment and preva-
lence rates, and medication review rates.
Relative contribution of explanatory factors and CCGs to 
outcomes variation
Table 5 summarises the correlations between the observed 
and model- predicted outcome scores. Correlations with 
predicted scores based on practice and CCG factors only 
(ie, factors from the multivariate solution) were all low 
to modest, with a maximum of 0.28 for the frailty coding 
outcome. Correlations with CCG means alone were all 
notably higher and ranged from 0.27 to 0.48. Correla-
tions with predictions based on factors plus CCG means 
were slightly higher still and exceeded or were near to 0.5 
for all three frailty identification outcomes.
DISCUSSION
Statement of the principal findings
Only around one in every six persons eligible for, and 
due, a frailty assessment under the GMS contract received 
one, with just over one- third assessed to be moderately or 
severely frail, meaning that overall 5% were coded as frail. 
Actual national rates of 12% for moderate and 3% for 
severe would be realistic estimates,19 practices thus iden-
tified 27% of the moderately frail population and 60% 
of those severely frail. Moderately frail people appear 
considerably underidentified. Regarding the contract 
frailty management requirements, rates of enriched SCRs 
and falls assessments were universally low, whereas most 
of the severely frail did receive a medication review.
There was wide variation in outcomes between both 
practices and CCGs. Relationships to practice and CCG 
factors were often low level but statistically significant 
due to the large practice sample. One strong associa-
tion was the finding that frailty assessment rates differed 
between health regions by a factor of almost two. Other 
strong associations were negative relationships between 
practice proportions of older patients and frailty assess-
ment and prevalence rates, and positive relationships 
between chronic caseloads (at practice or CCG level) and 
all frailty identification outcomes. All these relationships 
were curvilinear, mostly with outcome rates levelling off 
at higher levels of the explanatory factor. The finding 
that assessment rates were lower at practices with more 
older patients yet higher where the chronic caseload 
was greater implies targeting of those with greater chro-
nicity/severity. It was also notable that frailty assessment 
rates showed no associations with any healthcare capacity 
factors, although did vary by region and less strongly by 
practice QOF scores. Although practice size was not asso-
ciated with assessment rates, larger practices coded more 
assessed patients as frail.
Notwithstanding the above, for all outcomes the stron-
gest determinant of practice performance was CCG 
membership. Most of the funding for primary care now 
flows through CCGs and as of April 2018 over 90% of 
CCGs had become fully responsible for the commis-
sioning of GP services,20 making CCGs highly influential 
over primary care in their areas. Under NHS England’s 
Improvement and Assessment Framework, CCG perfor-
mance is assessed against a range of indicators, none of 
which relate to patient frailty.20 Thus, CCGs may have 
prioritised achieving the indicators they are judged on, 
with only a minority devoting time to developing and 
implementing policy and strategy to support the delivery 
of care to frail older patients.21 22 In CCGs where a frailty 
policy was lacking or weak, wide practice variation was 
possibly driven by degree of individual practice interest in 
frailty as an approach to structuring care and in meeting 
the contractual requirements. However, evaluating 
these assertions would require further research, such as 
in- depth surveying of CCG staff and review of published 
policies, which is beyond the scope of the present study.
Table 5 Correlations between observed and predicted frailty outcome scores
Outcome measure Practice and CCG factors* CCG means† Factors plus CCG means‡
Assessed for frailty 0.18 0.48 0.52
Coded moderately or severely frail out of 
those assessed
0.28 0.45 0.53
Coded moderately or severely frail out of 
those eligible for assessment
0.25 0.41 0.49
Severely frail receiving a medications 
review
0.05 0.27 0.27
Moderately or severely frail with a falls 
assessment
0.08 0.31 0.33
Moderately or severely frail with an 
enriched SCR
0.17 0.42 0.46
*Practice and CCG factors from the stepwise negative binomial regression model.
†CCG Empirical Bayes means only.
‡Practice and CCG factors plus CCG Empirical Bayes means.
CCG, Clinical Commissioning Group; SCR, Summary Care Record.
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Strengths and weaknesses of the study
The quality and consistency of frailty coding may have 
varied across practices reducing accuracy in identifying 
frailty and aspects of management. Many, if not most, 
practices may have used the electronic frailty index 
(EFI),19 a tool recommended by NHS England, to 
screen their patients for frailty based on information in 
the electronic patient record. Some practices may have 
‘batch’-coded frailty level based on the EFI,23 despite 
NHS England expressly stating that final diagnosis should 
be validated clinically.7 8 We cannot demonstrate how 
reliable the registered coding is and we could not find 
a precise way to identify ‘batch coding’ practices.23 It is 
possible that we lacked some key explanatory measures, 
even though we analysed commonly used indicators of 
healthcare demand and supply. We kept all variables in 
the analysis and relied on stepwise regression to remove 
the most colinear and identify the subset with the greatest 
explanatory power. We categorised continuous explana-
tory factors: exploratory analysis indicated a high number 
of non- linear relationships to outcomes and categorisa-
tion facilitated presentation of results as marginal means, 
which in our view made interpretation easier. Outcomes 
may have deviated from a true negative binomial distribu-
tion and to account for this, we used a robust estimator 
of variance for significance testing and CI construction.
Implication for clinicians and policymakers
Although the results demonstrated some associations 
that might be expected—such as higher rates of frailty 
coding at practices with higher chronic caseloads—other 
associations were counterintuitive: most notably lower 
assessment and prevalence rates at practices with greater 
representation of older patients. Thus, we do not believe 
the contract data currently provide a good proxy for 
actual prevalence. Our results suggest that targeting has 
led to practices assessing and coding principally severely 
frail individuals they may already know and be managing 
appropriately, and conversely to ‘miss’ the majority of 
moderately frail patients—those whom evidence suggests 
can benefit most from early interventions.24 25
Targeted screening may be a sensible pragmatic 
approach in a busy, overstretched, clinical environment. 
In a parallel study, we undertook in- depth interviews with 
staff at a number of practices,12 and many had developed 
a bespoke targeting strategy to implement the contrac-
tual requirements. Many also expressed concern about 
insufficient capacity in local services to manage all of the 
identified needs following the frailty assessments; profes-
sionals did not want to be in a sensitive position of just 
screening and classifying older adults as frail if they were 
unable to provide appropriate interventions.12 26
Notwithstanding such concerns, the evidence of this 
study suggests that CCGs are important drivers of practice- 
level implementation. CCGs may share the same concerns 
about the availability of suitable interventions and 
meeting increased levels of demand, but have ultimate 
responsibility for commissioning the necessary services. 
Hence, making further progress on implementation at 
the practice level may depend very much on achieving 
greater engagement of CCGs themselves, particularly in 
the commissioning of suitable interventions.
Comparison of our findings with other studies
The frailty contractual requirements are new, with limited 
published data on factors associated with successful 
implementation. The previous year’s contract data reveal 
that 9.5% were coded as moderately or severely frail in 
2017/201827: nearly double the rate for 2018/2019, 
suggesting that the earlier figure may have been inflated 
by batch- coding that was largely abandoned after NHS 
England expressed concerns. Falls assessments were 
introduced in 2018/2019 but only 3.7% of frail patients 
were reported to have received some form of falls assess-
ment, despite an estimated annual falls rate of 30% in 
those 65+ years.28 Barriers to implementing falls interven-
tions reported by GPs include insufficient time and doubt 
about the effectiveness of fall interventions,29 despite 
evidence that these can be effective.30 Medication reviews 
for the severely frail seem a complicated area that may 
need more guidance,31 due to their multimorbidity, poly-
pharmacy and limited life expectancy.31 32
CONCLUSION
CCG membership appears to be the strongest determi-
nant of GP practice engagement with the frailty contract, 
and fuller implementation at the practice level may 
depend on greater engagement of CCGs themselves, 
particularly in commissioning suitable interventions. 
Practices understandably targeted frailty assessments at 
patients likely to be severely frail, which can have resulted 
in underidentification of moderately frail individuals who 
might benefit most from early interventions. Frailty prev-
alence estimates based on the contract data may not accu-
rately reflect actual rates.
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